Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 27, Number 10—October 2021
Research Letter

SARS-CoV-2 Neutralization Resistance Mutations in Patient with HIV/AIDS, California, USA

Seth A. Hoffman, Cristina Costales, Malaya K. Sahoo, Srikanth Palanisamy, Fumiko Yamamoto, ChunHong Huang, Michelle Verghese, Daniel A. Solis, Mamdouh Sibai, Aruna Subramanian, Lucy S. Tompkins, Philip Grant, Robert W. Shafer, and Benjamin A. PinskyComments to Author 
Author affiliation: Stanford University School of Medicine, Stanford, California, USA

Main Article

Figure

Timeline of SARS-CoV-2 infection in a patient with HIV/AIDS, California, USA. Line breaks indicate separation in time intervals. Replication indicates detection of minus-strand RNA. ART, antiretroviral therapy; IgG, spike S1 domain IgG; IgM, spike receptor binding domain IgM; VL, HIV viral load; +, positive; –, negative.

Figure. Timeline of SARS-CoV-2 infection in a patient with HIV/AIDS, California, USA. Line breaks indicate separation in time intervals. Replication indicates detection of minus-strand RNA. ART, antiretroviral therapy; IgG, spike S1 domain IgG; IgM, spike receptor binding domain IgM; VL, HIV viral load; +, positive; –, negative.

Main Article

Page created: July 23, 2021
Page updated: September 19, 2021
Page reviewed: September 19, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external